Funding Opportunity PA-19-067 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to characterize antigen processing and presentation mechanisms used in the generation of novel peptidic and non-peptidic ligands presented by classical and non-classical MHC class I and class II molecules, and to determine the contribution of these unique antigenic ligands to: protective immune responses to infectious pathogens and/or vaccines; pathogen-associated immune pathogenesis; and/or in the induction/progression or prevention of immune-mediated diseases. These studies may facilitate the development of novel tools and reagents to advance design of immune-based therapeutics and vaccines.

Funding Opportunity PA-19-065 from the NIH Guide for Grants and Contracts. The purpose of the Funding Opportunity Announcement (FOA) is to promote the assessment and further development of simulation technologies intended to improve patient safety and healthcare outcomes provided by practicing patient care providers and experienced (not trainee) physicians. The FOA seeks applications directed toward three areas of research: 1) Skill Acquisition: to evaluate strategies and protocols for simulation-based methods for skill acquisition and maintenance by experienced clinicians; 2) Outcomes Assessment: to assess the relationship of simulation-based assessments of skills demonstrated by experienced clinicians with the quality of clinical care delivered by those clinicians, and to identify strategies to increase the quality of simulation-based assessments of skills; and 3) Technology Development: to develop virtual coaches by incorporating intelligent technologies into existing simulators to provide adaptive, cognitive assistance to coach experienced practitioners in retaining, retraining and improving performance levels in the context of the user environment (and physiological system as appropriate).

Funding Opportunity RFA-AI-18-053 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) will support basic science research to address outstanding questions in HIV latency and persistence by leveraging state-of-the-art single-cell multi-omics approaches. The goal is to interrogate HIV persistence with high molecular detail and resolution to better understand HIV persistence at the single-cell level. Emphasis will be on multi-omics or multiplex approaches integrating cutting-edge single-cell analysis technologies.

Negotiable: Paramount Recruitment: Technical Innovator - Bioinformatics Cambridge I have a great opportunity available to work with one of the leading organisations within bioinformati Cambridge, England

Notice NOT-OD-19-030 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-19-064 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will support pilot, feasibility or exploratory research in 5 priority areas in substance use epidemiology and health services, including: 1) responses to sudden and severe emerging drug issues (e.g. the ability to look into a large and sudden spike in opioid or synthetic cannabinoid use/overdoses in a particular community); 2) responses to emerging marijuana trends and topics related to the shifting policy landscape; 3) responses to unexpected and time-sensitive prescription drug abuse research opportunities (e.g., new state or local efforts); 4) responses to unexpected and time-sensitive medical system issues (e.g. opportunities to understand addiction services in the evolving health care system); and 5) responses to unexpected and time-sensitive criminal or juvenile justice opportunities (e.g. new system and/or structural level changes) that relate to drug abuse and access and provision of health care service. It should be clear that the knowledge gained from the proposed study is time-sensitive and that an expedited rapid review and funding are required in order for the scientific question to be answered (i.e. an imminent policy change will not allow for standard review and funding timeline).

Development of automated analysis methods to assess model quality and features, as well as the analysis of Molecular Dynamics simulations using statistical...
From Medical College of Wisconsin - Fri, 09 Nov 2018 03:07:39 GMT - View all Milwaukee, WI jobs

Development of automated analysis methods to assess model quality and features, as well as the analysis of Molecular Dynamics simulations using statistical...
From Medical College of Wisconsin - Fri, 09 Nov 2018 03:07:15 GMT - View all Milwaukee, WI jobs

Maintains a professional level of knowledge for at least one focused topic in medical and/or clinical informatics, to properly analyze data and maintain state...
From Medical College of Wisconsin - Thu, 08 Nov 2018 21:07:22 GMT - View all Milwaukee, WI jobs

Funding Opportunity RFA-DK-18-010 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for a Data Coordinating Center (DCC) that will support the Diabetic Foot Consortium (DFC) for clinical research on diabetic foot ulcers. The first studies will validate biomarkers that predict healing or response to therapy and assess infection or recurrence risk. Future research may involve clinical trials and studies on the pathophysiology of diabetic foot ulcers. Given the clinical complexity of diabetic wound healing, the applicant must have experience serving as the DCC on clinical studies of diabetic foot ulcers. The DCC will provide overall project coordination, administration, quality control, data management, and biostatistical support.

Negotiable: Paramount Recruitment: Lead Software Developer (Front-End) A new opportunity is now available for a talented Lead Developer to join a fantastic Biotech company, working in the field of Genomics and Bioinformatics! Using your background in UI Development and management, the Cambridge, England

Funding Opportunity PAR-19-061 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts aimed towards commercial product development in computational genomics, data science, statistics, and bioinformatics relevant to one or both of basic or clinical genomic science, and broadly applicable to human health and disease. This FOA supports genomics research developing innovative analytical and computational commercial products, methodologies, and approaches, early stage development of commercial tools and software, and refinement or hardening of software and tools of high value to the biomedical genomics community. Work supported under this FOA should be enabling for genomics and be generalizable or broadly applicable across diseases and biological systems.

Notice NOT-AG-18-038 from the NIH Guide for Grants and Contracts

Notice NOT-AG-18-042 from the NIH Guide for Grants and Contracts

Notice NOT-EB-18-033 from the NIH Guide for Grants and Contracts

Notice NOT-MH-18-069 from the NIH Guide for Grants and Contracts

Notice NOT-NS-19-020 from the NIH Guide for Grants and Contracts

Notice NOT-NS-19-021 from the NIH Guide for Grants and Contracts

Notice NOT-NR-18-023 from the NIH Guide for Grants and Contracts

Notice NOT-TW-18-009 from the NIH Guide for Grants and Contracts